Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes

被引:62
作者
Varani, K.
Vincenzi, F.
Tosi, A.
Targa, M.
Masieri, F. F. [2 ]
Ongaro, A. [2 ]
De Mattei, M. [2 ]
Massari, L. [3 ]
Borea, P. A. [1 ]
机构
[1] Univ Ferrara, Fac Med, Dept Clin & Expt Med, Pharmacol Unit, I-44100 Ferrara, Italy
[2] Univ Ferrara, Dept Morphol & Hystol, I-44100 Ferrara, Italy
[3] Univ Ferrara, Orthopaed Clin, Dept Biomed Sci & Adv Therapies, I-44100 Ferrara, Italy
关键词
adenosine receptors; human synoviocytes; mRNA; Western blotting; receptor binding; cAMP; MAPK p38; NF-kappa B; TNF-alpha; IL-8; TUMOR-NECROSIS-FACTOR; FACTOR-KAPPA-B; FIBROBLAST-LIKE SYNOVIOCYTES; FACTOR-ALPHA RELEASE; TNF-ALPHA; BIOCHEMICAL-CHARACTERIZATION; ANTAGONIST RADIOLIGAND; INDUCED ARTHRITIS; A(2A); ACTIVATION;
D O I
10.1111/j.1476-5381.2010.00667.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and purpose: Adenosine is an endogenous modulator, interacting with four G-protein coupled receptors (A(1), A(2A), A(2B) and A(3)) and acts as a potent inhibitor of inflammatory processes in several tissues. So far, the functional effects modulated by adenosine receptors on human synoviocytes have not been investigated in detail. We evaluated mRNA, the protein levels, the functional role of adenosine receptors and their pharmacological modulation in human synoviocytes. Experimental approach: mRNA, Western blotting, saturation and competition binding experiments, cyclic AMP, p38 mitogen-activated protein kinases (MAPKs) and nuclear factor (NF)-kappa B activation, tumour necrosis factor alpha (TNF-alpha) and interleukin-8 (IL-8) release were assessed in human synoviocytes isolated from patients with osteoarthritis. Key results: mRNA and protein for A(1), A(2A), A(2B) and A(3) adenosine receptors are expressed in human synoviocytes. Standard adenosine agonists and antagonists showed affinity values in the nanomolar range and were coupled to stimulation or inhibition of adenylyl cyclase. Activation of A(2A) and A(3) adenosine receptors inhibited p38 MAPK and NF-kappa B pathways, an effect abolished by selective adenosine antagonists. A(2A) and A(3) receptor agonists decreased TNF-alpha and IL-8 production. The phosphoinositide 3-kinase or G(s) pathways were involved in the functional responses of A(3) or A(2A) adenosine receptors. Synoviocyte A(1) and A(2B) adenosine receptors were not implicated in the inflammatory process whereas stimulation of A(2A) and A(3) adenosine receptors was closely associated with a down-regulation of the inflammatory status. Conclusions and implications: These results indicate that A(2A) and A(3) adenosine receptors may represent a potential target in therapeutic modulation of joint inflammation.
引用
收藏
页码:101 / 115
页数:15
相关论文
共 53 条
  • [1] Abeles AM, 2006, BULL HOSP JT DIS, V64, P20
  • [2] Alexander SPH, 2009, BRIT J PHARMACOL, V158, pS1, DOI 10.1111/j.1476-5381.2009.00499.x
  • [3] Topical Therapy for Osteoarthritis: Clinical and Pharmacologic Perspectives
    Altman, Roy
    Barkin, Robert L.
    [J]. POSTGRADUATE MEDICINE, 2009, 121 (02) : 139 - 147
  • [4] Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases
    Barnes, PJ
    Larin, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) : 1066 - 1071
  • [5] Synovial tissue inflammation in early and late osteoarthritis
    Benito, MJ
    Veale, DJ
    Fitzgerald, O
    van den Berg, WB
    Bresnihan, B
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (09) : 1263 - 1267
  • [6] FULL AND PARTIAL AGONISTIC BEHAVIOR AND THERMODYNAMIC BINDING PARAMETERS OF ADENOSINE-A1-RECEPTOR LIGANDS
    BOREA, PA
    VARANI, K
    DALPIAZ, A
    CAPUZZO, A
    FABBRI, E
    IJZERMAN, AP
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1994, 267 (01): : 55 - 61
  • [7] Inhibition of synoviocyte collagenase gene expression by adenosine receptor stimulation
    Boyle, DL
    Sajjadi, FG
    Firestein, GS
    [J]. ARTHRITIS AND RHEUMATISM, 1996, 39 (06): : 923 - 930
  • [8] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [9] Purinergic signalling and disorders of the central nervous system
    Burnstock, Geoffrey
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (07) : 575 - 590
  • [10] CABRERA MCG, 2006, BR J NUTR S1, V96, pS31